ID: 218414 Queen Mary University London Postgraduate Certification in Neuromodulation- Accreditation in Neuromodulation

ABSTRACT

Introduction: There is a distinct unmet need in structured, curriculum based, unbiased education in neuromodulation. Current teaching is through sporadic industry workshops, cadaver courses and peer proctorship. The COVID pandemic has created a unique opportunity where online platforms have enabled education to be delivered remotely in both synchronous and asynchronously. The William Harvey Research Institute, Queen Mary University, London, UK have initiated University based accreditation- Post Graduate Certificate in neuromodulation (PGCert) that provides candidate a qualification in one academic year through part-time study. Method(s) The program underwent rigorous staged university approval process (figure 1). To ensure market feasibility, two short proof of concept CPD programs "Executive Education in Neuromodulation (EEPIN)" were delivered in 2021. These courses attracted 87 candidates across Australia, Singapore, India, Germany, Poland, Czech Republic, Ireland, and UK. The faculty includes key opinion leaders that will deliver the program ensuring the candidates gain academic background and specialist skills to understand safe practice of neuromodulation. The PGCert advisory board has been established to ensure strict governance in terms of content and unbiased delivery confirming ACCME guidance. In order to obtain PGCert, candidates are required to complete 4 x 15 credit modules (60 credits). The four modules include Anatomy & Neurophysiology;Patient care and Procedurals skills;Devices and available technology;Intrathecal drug delivery for cancer and non-cancer pain. The modular nature of the program is designed to provide cumulative knowledge, from basic science to clinical application in line with the best available evidence. The modules comprise nine lectures, spreading over three consecutive days, followed by a written assignment with 40 direct contact hours in each module. The webpage can be accessed at Results: The anonymous data from EEPIN reported on Likert scale 1-5 Objectives defined 30.6% - 4 and 69.4% -5;Relevance of topics 10.2%- 4 and 89.8% -5;Content of presentations 22.4%- 4 and 77.6% -5;Organization 24.5% -4 and 69.4% -5;Candidate faculty interaction 14.3% -4 and 81.6% -5. 97% of the EEPIN candidates recommended the program to others whilst 81.8% expressed their strong interest to enroll for university-based post graduate qualification if offered. Conclusion(s) This PGcert Neuromodulation is a unique, university accredited program that provides qualification in neuromodulation with access to a flexible online e-learning platform to discuss and exchange ideas, share knowledge in candidate's own time. This will support the ongoing need for formal curriculum-based education in neuromodulation. Disclosure Kavita Poply, PHD None, Phillippe Rigoard None, Jan Kallewaard, MD/PhD None, FRANK J.P.M. HUYGEN, MD PhD ABBOTT Speakers Bureau, Saluda Consulting Fee, Boston Scientific Consulting Fee, Grunenthal Speakers Bureau, Pfizer Speakers Bureau, Ashish Gulve, FRCA, FFPMRCA, FFPMCAI, DPMed, FCARCSI, MD, MBBS None, Ganesan Baranidharan, FRCA None, Sam ELDABE, MD, FRCA, FFPMRCA Medtronic Consulting Fee, Medtronic Contracted Research, Mainstay Medical Consulting Fee, Saluda Medical Consulting Fee, Boston Scientific Contracted Research, Saluda Medical Contracted Research, James Fitzgerald, MA,PhD St Jude Medical Consultant Self, Medtronic Consulting Fee, UCB Contracted Research, Merck Contracted Research, Serge Nikolic, MD None, Stana Bojanic, BSc MBBS FRCS (SN) Abbott Contracted Research, Habib Ellamushi None, Paresh Doshi, MS MCh None, Preeti Doshi, MBBS, MD, FRCA None, Babita Ghai, MBBS, MD, DNB None, Marc Russo, MD Presidio Medical Ownership Interest, Saluda Medical Ownership Interest, Boston Scientific Contracted Research Self, Mainstay Medical Contracted Research Self, Medtronic Contracted Research Self, Nevro Contracted Research Self, Saluda Medical Contracted Research Self, Presidio Medical Contracted Research Self, Freedom Ne ro Ownership Interest - Own Stocks Self, Lungpacer Ownership Interest - Own Stocks Self, SPR Therapeutics Ownership Interest - Own Stocks Self, Lawrence Poree, MD,MPH,PHD Medtronic Consulting Fee Self, Saluda Medical Contracted Research Family, Nalu Medical Contracted Research Family, Gimer Medical Consulting Fee Self, Nalu Medical Consulting Fee Self, Saluda Medical Consulting Fee Self, Nalu Ownership Interest, Saluda Inc Ownership Interest, Alia Ahmad None, Alaa Abd Sayed, MD Medtronic, Abbott, SPR and StimWave Consulting Fee, Salim Hayek, MD,PhD None, CHRISTOPHER GILLIGAN, MD MBA Persica Consulting Fee Self, Saluda Consulting Fee Self, Mainstay Medical Contracted Research Self, Sollis Therapeutics Contracted Research Self, Iliad Lifesciences, LLC Owner individuals with legal ownership in a company, Vivek Mehta NoneCopyright © 2023